Navigation Links
Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
Date:5/9/2008

ndard therapy or for which no curative standard therapy exists. The primary objectives of the trial include determining the Minimum Effective Immunomodulatory Dose (MED) of cyclophosphamide to obtain successful immune modulation. Secondary objectives include determining the safety profile of the combination and gathering any evidence of anti-tumour activity.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com.

Ref:

Clin. Cancer Res. 2008 14:259-269

Cancer Gene Ther. 2006 Aug; 13(8): 815-8

Cancer Res, 2003 Jan 15; 63(2):348-53

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the Company's expectations related to the U.K. combination REOLYSIN(R)/cyclophosphamide clinical trial, and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the tolerability of REOLYSIN(R) outside a controlled test, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech Inc. Announces Details of 2008 Annual Shareholder Meeting
2. Oncolytics Biotech Inc. Announces 2008 First Quarter Results
3. Oncolytics Biotech Inc. Announces Journal of Immunology Publication on Reovirus Activation of Dendritic Cells
4. Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma
5. Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Multiple Myeloma at AACR Annual Meeting
6. Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Pediatric Sarcomas at AACR Annual Meeting
7. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Paclitaxel and Carboplatin Trial
8. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Combination REOLYSIN(R) and Carboplatin/Paclitaxel Trial
9. Oncolytics Biotech Inc. Announces Issuance of 26th U.S. Patent
10. Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to REOLYSIN(R) during a Phase I Clinical Trial
11. Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)... The arm of the federal government responsible fo...ions across the country has called on experts from...paper that will lay out how government and industr...ociated with nanotechnology to the media and the p...ube has been negotiating this project for nearly 1...
(Date:5/12/2008)... SAN DIEGO, May 12 /- Ana...ed today that it will present at the Rodman &,Rens...day, May 19, 2008 at,10:00 a.m. CEST (4:00 a.m. ED...in Monte Carlo, Monaco. Steve Worland, Ph.D., Pres...present an overview of Anadys and an,update on its...
(Date:5/12/2008)... MOUNTAIN VIEW, Calif., May 12 /PRNewswire-First...XA ) reported today financial results for,its fisc...date on the,Company,s progress with its product ca...uarter, as reported in accordance with accounting ... (GAAP), was $14.6 million, compared,to a net loss...
(Date:5/12/2008)... Company Announces Closing of Insider Round of Fi...swire/ -- Continued increasing sales of,RedPath In...eled the,company,s expansion and relocation into n...d the growth of the company,s work force which now...ckdrop, the company announced,today that it has cl...
Breaking Biology Technology:Federal government taps NC State experts to explain nanotech risks 2Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences 2Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 2Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 3Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 4Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 5Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 6Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 7Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 8Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 9Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates 10Expansion and Relocation to New, State-Of-The-Art Facilities Marks Milestone in Effort to Roll Out New Tool for Cancer Diagnosis 2Expansion and Relocation to New, State-Of-The-Art Facilities Marks Milestone in Effort to Roll Out New Tool for Cancer Diagnosis 3
...Steve Matheys Green Bay, Wis. - For six years, ... Schneider National , and his experience during t...ving as a CIO can be a great training ground for b...,Provided the company entrusts you with a high lev... serves as executive vice president of sales, mark...
...ilwaukee, Wis . - He is fast becoming one of the m... technology education, and if he has his way chief...of prospective employees to choose from when they ...will speak at a June 12 luncheon during the Wisco... pre-engineering teacher by trade, and an advocate...
...adison, Wis. - Claiming that patents and publicat...atents are irrelevant to the isolation and prolife...in Alumni Research Foundation has filed a respon... Patent and Trademark Office . , ,Those observatio...g director of WARF, were supported by Dr. Colin S...
...adison, Wis . - Did the state of Wisconsin imprope... package installed by Menasha Corp. ? , ,The Wis...ter agreeing last week to hear the case, and there...ses throughout Wisconsin, including $600,000 for M...fied software, which unlike off-the-shelf software...
Other Biology Technology:Visions: Matheys says CIO role is good training for executive suite 2Visions: Matheys says CIO role is good training for executive suite 3Visions: Matheys says CIO role is good training for executive suite 4Jump starting technology education 2Jump starting technology education 3WARF questions relevancy of documents used to uphold patent challenge 2WARF questions relevancy of documents used to uphold patent challenge 3
(Date:5/9/2008)...f ornamental stones has grown all over the world i...t to the aesthetics of natural stones in buildings...is, undoubtedly, the ornamental stone par excellen...ve architectural or sculptural works which constit...ritage. Despite this, nowadays we have a very limi...
(Date:5/9/2008)...Speaks, the worlds largest autism advocacy organiz...ional collaboration with North, South and Central ...o raise awareness and develop research expertise f...iagnosis and enhanced service delivery across the ...artnerships with countries that have different cul...
(Date:5/9/2008)...esented at the May 2008 Pediatric Academic Societi...Meeting indicate that childhood and adolescent obe...ion, which relates to cardiac health. , Obesity ... past 20 years and obesity in adults has been link...sity in children is also increasing and many cardi...
(Date:5/9/2008)...r has won a share of grants totalling over 1m to t...ve, Dr. Declan Bates, a senior lecturer in the Dep...ter, is co-recipient of 1,068,000 in the form of j...and Physical Sciences Research Council (EPSRC) and...ciences Research Council (BBSRC). , The grants a...
Breaking Biology News(10 mins):Development of new techniques to understand marble quality and durability 2Autism Speaks announces multinational initiative 2Study supports reason for concern in childhood and adolescent obesity 2Engineer to spearhead research into cell metabolism and medical injuries 2Kendle Promotes Simon S Higginbotham to President 3B Appoints Alan J Boyce as Chief Marketing Officer 16785 1Kendle Promotes Simon S Higginbotham to President 3B Appoints Alan J Boyce as Chief Marketing Officer 16785 2Kendle Promotes Simon S Higginbotham to President 3B Appoints Alan J Boyce as Chief Marketing Officer 16785 3Tip sheet for the Annals of Internal Medicine April 15 2008 issue 16782 1Tip sheet for the Annals of Internal Medicine April 15 2008 issue 16782 2Bischof Promoted to Vice President Enterprise Risk Management at Conseco 16777 1Health Care Workforce Experts Available to Comment on IOM Report on Aging Baby Boomers and Impending Medical System Crisis 16772 1Health Care Workforce Experts Available to Comment on IOM Report on Aging Baby Boomers and Impending Medical System Crisis 16772 2
...est - pieces of real estate on the Brandeis Univer...e-art superconducting magnet for use in researchin...mes and other proteins. , The installation of the...cently completed in a specially built facility on ...ns, the magnetic resonance (MR) spectrometer was f...
...ptics and antibiotics in hospitals is actually put... bacterial infection? , Yes, argues Mark Spigelman...ter for the Study of Infectious and Tropical Disea...y of Medicine. Prof. Spigelman points to a recent ...ons in patients (the worst in Europe) in British p...
...wiring, that differs markedly from the cellular ci... could lead to the development of antimalarial dru...SD have discovered that the single-cell parasite r...ear worldwide from malaria has protein "wiring" th... other higher organisms, a finding which could lea...
...and Peiming Zhang has developed a new, breakthroug...Their results, published in the journal Proceeding... for the first time, the possibility of directly i...olymorphisms (SNPs), by means of measuring the ele...SNPs are buried in the 3 billion DNA bases of th...
Other Biology News:Superconducting magnet attracts molecular research 2'Good' bacteria could save patients from infection infection by deadlier ones 2Researchers develop new method to help find deadly malaria parasite's Achilles heel 2Researchers develop new method to help find deadly malaria parasite's Achilles heel 3ASU researchers 'wire' DNA to identify mutations 2ASU researchers 'wire' DNA to identify mutations 3
2.0 GHz Compaq Computer with 512 MB RAM, 32 MB AGP Graphics Card, 40 GB Hard Drive, 1 Serial Port & Open PCI Slot, Windows 2000 OS, MS Office, CD Read/Writer and 18 Flat Panel Monitor
...d efficient removal of short primers, dNTPs, enzym...products (Figure 1). The simple PureLink bind/wash...tions for fragments >100 bp or >300 bp* , can be p...format , takes ,Two proprietary buffers are supp...
Mouse, normal organs, perfusion fixation from IMGENEX
Immunogen: Recombinant full length protein. Storage: -20 C, Avoid Freeze/Thaw Cycles
Biology Products: